Obesity is a major health issue worldwide, and finding effective treatments has been a top priority. Now, there's renewed interest in a new medication called Rybelsus. This drug, which belongs to a class of medications known as GLP-1 receptor agonists, acts on the body's ability to regulate blood sugar. While initially developed for type 2 diabetes